A prospective, multicenter, open label, phase IV study to evaluate safety and efficacy of Adapalene 0.3% - Benzoyl peroxide 2.5% gel in subjects with Moderate to Severe Acne Vulgaris.
An Prospective,open label,multicentric, single-arm, non-comparative post marketing clinical study to evaluate effectiveness and safety of Restylane® Lidocaine in subjects undergoing treatment for facial wrinkles and lip augmentation and Restylane® Perlane Lidocaine in subjects undergoing treatment for facial folds and volume loss
Evaluation of â??Quality of Lifeâ?? and in-use tolerance in women with facial melasma, after using a triple combination drug (TRI-LUMA Cream)
100 项与 Galderma India Pvt Ltd. 相关的临床结果
0 项与 Galderma India Pvt Ltd. 相关的专利(医药)
100 项与 Galderma India Pvt Ltd. 相关的药物交易
100 项与 Galderma India Pvt Ltd. 相关的转化医学